Published in Am J Ophthalmol on September 06, 2008
Forty-two-month outcome of intravitreal bevacizumab in myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (2014) 1.99
Summary of prognostic factors for choroidal neovascularization due to pathological myopia treated by intravitreal bevacizumab injection. Graefes Arch Clin Exp Ophthalmol (2012) 1.97
Comparison of foveal-sparing with foveal-involving photodynamic therapy for myopic choroidal neovascularization. Eye (Lond) (2013) 1.03
Myopic choroidal neovascularisation: current concepts and update on clinical management. Br J Ophthalmol (2014) 1.02
Factors affecting visual outcome of myopic choroidal neovascularization treated with verteporfin photodynamic therapy. Int J Ophthalmol (2013) 1.00
Bevacizumab for choroidal neovascularization secondary to pathologic myopia: Is there a decline of the treatment efficacy after 2 years? Graefes Arch Clin Exp Ophthalmol (2010) 0.97
Antiangiogenic therapy for ischemic retinopathies. Cold Spring Harb Perspect Med (2012) 0.89
Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (2012) 0.89
Prognostic factors for visual outcomes 2-years after intravitreal bevacizumab for myopic choroidal neovascularization. Eye (Lond) (2011) 0.89
The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review. BMJ Open (2014) 0.89
Intravitreal bevacizumab to treat myopic choroidal neovascularization: 2-year outcome. Graefes Arch Clin Exp Ophthalmol (2010) 0.88
Recent trends in the management of maculopathy secondary to pathological myopia. Graefes Arch Clin Exp Ophthalmol (2011) 0.87
Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses. Graefes Arch Clin Exp Ophthalmol (2011) 0.86
A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV. Graefes Arch Clin Exp Ophthalmol (2014) 0.86
Intravitreal bevacizumab on myopic choroidal neovascularization that was refractory to or had recurred after photodynamic therapy. Graefes Arch Clin Exp Ophthalmol (2009) 0.85
Sensitivity of fluorescein angiography alone or with SD-OCT for the diagnosis of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (2013) 0.83
Intravitreal bevacizumab for choroidal neovascularization secondary to non-age-related macular degeneration. J Ophthalmic Vis Res (2010) 0.82
Macular detachment after successful intravitreal bevacizumab for myopic choroidal neovascularization. Jpn J Ophthalmol (2011) 0.81
Intravitreal bevacizumab for CNV-complicated tilted disk syndrome. Graefes Arch Clin Exp Ophthalmol (2009) 0.81
Ranibizumab for the treatment of degenerative ocular conditions. Clin Ophthalmol (2014) 0.80
Predictive factors for visual outcome to intravitreal bevacizumab in young Chinese patients with myopic choroidal neovascularization. Retina (2011) 0.80
Intravitreal bevacizumab versus photodynamic therapy for myopic choroidal neovascularization in a North-African population. Graefes Arch Clin Exp Ophthalmol (2011) 0.79
[Therapy of myopic choroidal neovascularization]. Ophthalmologe (2012) 0.79
Treatment of myopic choroidal neovascularization with posterior sub-Tenon's bevacizumab injection (Avastin ®). Int Ophthalmol (2014) 0.78
Negative correlation between aqueous vascular endothelial growth factor levels and axial length. Jpn J Ophthalmol (2011) 0.78
Aqueous Concentrations of Vascular Endothelial Growth Factor in Eyes with High Myopia with and without Choroidal Neovascularization. J Ophthalmol (2013) 0.77
Outcome of photodynamic therapy in choroidal neovascularization due to pathologic myopia and related factors. Int Ophthalmol (2012) 0.76
Intravitreal aflibercept for the treatment of choroidal neovascularization associated with pathologic myopia: a pilot study. Clin Ophthalmol (2016) 0.75
Comparison of 1-year therapeutic effect of ranibizumab and bevacizumab for myopic choroidal neovascularization: a retrospective, multicenter, comparative study. BMC Ophthalmol (2014) 0.75
Single intravitreal ranibizumab for myopic choroidal neovascularization. Clin Ophthalmol (2011) 0.75
Batch-related sterile endophthalmitis following intravitreal injection of bevacizumab. Indian J Ophthalmol (2014) 0.75
Meta-analysis of best corrected visual acuity after treatment for myopic choroidal neovascularisation. Int J Ophthalmol (2014) 0.75
Only first intravitreal bevacizumab injection achieves statistically significant visual improvement in naïve myopic choroidal neovascularization. Clin Ophthalmol (2012) 0.75
Combined therapy with bevacizumab and photodynamic therapy for myopic choroidal neovascularization: A one-year follow-up controlled study. Int J Ophthalmol (2014) 0.75
Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Intravitreal aflibercept for myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
Epidemiology, treatment pattern and health care utilization of myopic choroidal neovascularization: a population based study. Jpn J Ophthalmol (2017) 0.75
Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med (2004) 4.91
Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Vis Sci (2009) 3.68
Otx2 homeobox gene controls retinal photoreceptor cell fate and pineal gland development. Nat Neurosci (2003) 3.08
Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol (2002) 2.59
Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol (2010) 2.39
Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation. Nat Neurosci (2008) 2.35
Math3 and NeuroD regulate amacrine cell fate specification in the retina. Development (2002) 2.07
Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology (2008) 1.96
Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. Ophthalmology (2009) 1.96
One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology (2007) 1.81
A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology (2009) 1.80
Functional bioengineered corneal epithelial sheet grafts from corneal stem cells expanded ex vivo on a temperature-responsive cell culture surface. Transplantation (2004) 1.76
Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci (2009) 1.75
Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization. Am J Ophthalmol (2009) 1.60
Polypoidal choroidal vasculopathy and treatments. Curr Opin Ophthalmol (2008) 1.59
Nuclear cataract caused by a lack of DNA degradation in the mouse eye lens. Nature (2003) 1.55
Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema. Acta Ophthalmol (2008) 1.55
Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration. Retina (2012) 1.53
Complications in patients after intravitreal injection of bevacizumab. Acta Ophthalmol (2007) 1.53
Human limbal epithelium contains side population cells expressing the ATP-binding cassette transporter ABCG2. FEBS Lett (2004) 1.51
Chandelier retroillumination-assisted torsional oscillation for cataract surgery in patients with severe corneal opacity. J Cataract Refract Surg (2007) 1.46
Nonaxoplasmic transfer of indocyanine green into the optic nerve after intravitreal application. Retina (2004) 1.44
Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice. J Clin Invest (2011) 1.44
Potent retinal arteriolar traction as a possible cause of myopic foveoschisis. Am J Ophthalmol (2005) 1.43
Histological evaluation of mechanical epithelial separation in epithelial laser in situ keratomileusis. J Cataract Refract Surg (2009) 1.40
PAX6 mutation as a genetic factor common to aniridia and glucose intolerance. Diabetes (2002) 1.39
Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology (2009) 1.37
Functional human corneal endothelial cell sheets harvested from temperature-responsive culture surfaces. FASEB J (2005) 1.37
Correlation of fundus autofluorescence with photoreceptor morphology and functional changes in eyes with retinitis pigmentosa. Acta Ophthalmol (2010) 1.35
Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol (2006) 1.34
Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol Vis (2007) 1.33
N-Cadherin is expressed by putative stem/progenitor cells and melanocytes in the human limbal epithelial stem cell niche. Stem Cells (2006) 1.33
Limbal epithelial side-population cells have stem cell-like properties, including quiescent state. Stem Cells (2005) 1.33
Optical coherence tomographic findings of macular holes and retinal detachment after vitrectomy in highly myopic eyes. Am J Ophthalmol (2003) 1.30
Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography. Ophthalmology (2008) 1.28
Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2012) 1.28
Retardation of retinal vascular development in apelin-deficient mice. Arterioscler Thromb Vasc Biol (2008) 1.27
Tractional internal limiting membrane detachment in highly myopic eyes. Am J Ophthalmol (2006) 1.25
Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study. Ophthalmology (2008) 1.23
Wavefront aberrations measured with Hartmann-Shack sensor in patients with keratoconus. Ophthalmology (2002) 1.22
Higher-order aberrations due to the posterior corneal surface in patients with keratoconus. Invest Ophthalmol Vis Sci (2008) 1.21
Magnitude and orientation of Zernike terms in patients with keratoconus. Invest Ophthalmol Vis Sci (2007) 1.20
Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks. Am J Ophthalmol (2009) 1.19
Three-dimensional optical coherence tomographic findings in central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol (2006) 1.17
Generation of corneal epithelial cells from induced pluripotent stem cells derived from human dermal fibroblast and corneal limbal epithelium. PLoS One (2012) 1.17
Bacteriologic profile of the conjunctiva in the patients with dry eye. Am J Ophthalmol (2008) 1.17
Vitrectomy and internal limiting membrane peeling for myopic foveoschisis. Am J Ophthalmol (2004) 1.17
Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I. J Cell Sci (2004) 1.16
Effect of transcorneal electrical stimulation in patients with nonarteritic ischemic optic neuropathy or traumatic optic neuropathy. Jpn J Ophthalmol (2006) 1.15
Chronic photo-oxidative stress and subsequent MCP-1 activation as causative factors for age-related macular degeneration. J Cell Sci (2012) 1.15
Wide-angle viewing lens for vitrectomy. Am J Ophthalmol (2004) 1.14
Serial measurements of higher-order aberrations after blinking in patients with dry eye. Invest Ophthalmol Vis Sci (2008) 1.13
Evaluation of phosphenes elicited by extraocular stimulation in normals and by suprachoroidal-transretinal stimulation in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol (2007) 1.12
Retinal vascular microfolds in highly myopic eyes. Am J Ophthalmol (2005) 1.11
Generation of a transgenic rabbit model of retinal degeneration. Invest Ophthalmol Vis Sci (2008) 1.11
Changes of ocular aberration with accommodation. Am J Ophthalmol (2002) 1.11
Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol (2010) 1.11
Age-related changes in ocular and corneal aberrations. Am J Ophthalmol (2004) 1.10
Characteristics of central serous chorioretinopathy complicated by focal choroidal excavation. Retina (2014) 1.10
Transcorneal electrical stimulation promotes the survival of photoreceptors and preserves retinal function in royal college of surgeons rats. Invest Ophthalmol Vis Sci (2007) 1.10
Transcorneal electrical stimulation rescues axotomized retinal ganglion cells by activating endogenous retinal IGF-1 system. Invest Ophthalmol Vis Sci (2005) 1.10
Effect of tear film break-up on higher-order aberrations measured with wavefront sensor. Am J Ophthalmol (2002) 1.10
Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy. Am J Pathol (2010) 1.09
Age at onset curves of retinitis pigmentosa. Arch Ophthalmol (2008) 1.09